Results 131 to 140 of about 21,136 (238)

Promise to Practice: Reimagining Artificial Intelligence for Equitable Global Health Impact. [PDF]

Ann Glob Health
Patel S, Robsky KO, Mao W, Usman U, Garcia L, Omobowale O, Mchunu G, Sung J, Clifford G, Madabhushi A, Ismail A, Bidiwala S, Mehmood S, Ngaruiya C, Kilgore PE, Martin K.   +15 more
europepmc   +1 more source

Summary of the International Conference on Emerging Infectious Diseases US‐Japan Cooperative Medical Science Program, Bangkok, 1997 [PDF]

The Journal of Infectious Diseases, 1998
A A, Mahmoud, J, La Montagne, Y, Takeda
openaire   +2 more sources

The First Global Forum of WHO Collaborating Centres and the One Health Summit, a landmark event redefining the future of global health science, with a reviewed history and update of the One Health concept. [PDF]

One Health
Mas-Coma S, Bargues MD.
europepmc   +1 more source

Repurposing FDA‐Approved Drugs to Inhibit Fungal PPTases for Broad‐Spectrum Synergy

Advanced Science, EarlyView.
Fungal secondary metabolites serve as crucial virulence effectors; however, the potential of their biosynthetic pathways as antifungal targets remains inadequately comprehended. Repurposed FDA‐approved drugs inhibit fungal PPTase (essential for secondary metabolism) in vivo.
Zili Song, Can Zhao, Qiaoling Wang, Hongjiao Zhang, Xiao Liu, Linqi Wang, Michael Bromley, Wen‐Bing Yin   +7 more
wiley   +1 more source

Biographical Feature: Joseph E. McDade, PhD. [PDF]

J Clin Microbiol
Munson E.
europepmc   +1 more source

Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T‐Cell Immunity

Advanced Science, EarlyView.
Clinical intramuscular thymus transplantation yields only short‐lived efficacy and marginal therapeutic benefits. Benefiting from the spleen's intrinsic strengths—rapid vascular perfusion, abundant developmental factors, and resident progenitors—the intrasplenic thymic grafts achieve robust thymic regeneration and substantial T‐cell reconstitution ...
Shaocong Wang, Zijian Zhang, Fulin Dai, Zhijie Yin, Zhen Xing, Yurong Li, Haochong Lei, Junfeng Zhang, Chunyan Liu, Yan Li, Lei Dong   +10 more
wiley   +1 more source

ProMED-mail: Background and Purpose

Emerging Infectious Diseases, 2001
Jack Woodall, Charles H. Calisher
doaj   +1 more source

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023¹. [PDF]

Emerg Infect Dis
Murray K, Grahn E, Stacey A, Hughes C, Sheorey H, Constantinoiu C, Kuma L, Bradbury RS.   +7 more
europepmc   +1 more source

Corynoxine Inhibits Tumor Growth via Targeting NQO1 and Modulating the PTPA–NQO1/PP2A Switch to Activate PP2A

Advanced Science, EarlyView.
Corynoxine exerts potent broad‐spectrum anticancer activity by directly targeting NQO1. This interaction dissociates the oncogenic NQO1‐PTPA complex, releasing PTPA to robustly activate the tumor suppressor PP2A. Consequently, downstream Raf/MEK/ERK and PI3K/AKT signaling pathways are suppressed, downregulating c‐Myc and driving tumor regression ...
Guoqing Hou, Li Lin, Mengjie Xia, Ruohan Liang, Yueyue Zhang, Linna Du, Xuan Cao   +6 more
wiley   +1 more source

Institutional Review Boards: Developing Countries Consideration

Emerging Infectious Diseases, 2001
Jean William Pape
doaj   +1 more source